HomeBUSINESS
BUSINESS

Ono to Boost Oncology Reps to Prep for Opdivo Label Expansions
(May.11.2018)

Ono President Gyo Sagara
Ono Pharmaceutical will ramp up the number of sales reps specializing in oncology from the current 250 to 280 by the end of March next year, gearing up for an array of label expansions anticipated for its PD-1 inhibitor Opdivo (nivolumab), President Gyo Sagara said on May 10 ...
(LOG IN FOR FULL STORY)

Notice

 The next ebook update will be provided on August 20.

News Calendar